ASO visual abstract: health care utilization, costs, and cost-effectiveness for patients undergoing laparoscopic and open hemihepatectomy: a secondary analysis of the ORANGE II PLUS randomised controlled, phase 3, superiority trial
Olij, Bram Pilz da Cunha, Gabriela Kimman, Merel Ratti, Francesca Abu Hilal, Mohammad Troisi, Roberto I Sutcliffe, Robert P Besselink, Marc G Aroori, Somaiah Menon, Krishna V
Olij, Bram
Pilz da Cunha, Gabriela
Kimman, Merel
Ratti, Francesca
Abu Hilal, Mohammad
Troisi, Roberto I
Sutcliffe, Robert P
Besselink, Marc G
Aroori, Somaiah
Menon, Krishna V
Abstract
No abstract available
MIDER Authors
Affiliations
Date
2026-04
Type
Article
Subject
Collections
Citation
Olij B, Pilz da Cunha G, Kimman M, Ratti F, Abu Hilal M, Troisi RI, Sutcliffe RP, Besselink MG, Aroori S, Menon KV, Edwin B, D'Hondt M, Lucidi V, Ulmer TF, Díaz-Nieto R, Soonawalla Z, White S, Sergeant G, Coolsen MME, Kümmerli C, Scuderi V, Berrevoet F, Vanlander A, Marudanayagam R, Tanis PJ, Dewulf MJL, Fichtinger RS, Eminton ZB, Neumann UP, Brandts L, Pugh SA, Fretland ÅA, Primrose JN, van Dam RM; ORANGE II PLUS Collaborative. ASO Visual Abstract: Health Care Utilization, Costs, and Cost-Effectiveness for Patients Undergoing Laparoscopic and Open Hemihepatectomy: A Secondary Analysis of the ORANGE II PLUS Randomised Controlled, Phase 3, Superiority Trial. Ann Surg Oncol. 2026 Apr;33(4):2953-2954. doi: 10.1245/s10434-025-19033-7.